|
Post by aggie2039 on Jun 7, 2023 8:53:34 GMT -5
EAST GREENSBORO, N.C. (June 7, 2023) – North Carolina Agricultural and Technical State University and Merck (NYSE:MRK) announced a collaboration agreement today for Merck to build a biotechnology training center at Gateway Research Park’s South Campus in East Greensboro. Merck will outfit the facility with the equipment and classroom spaces necessary to provide and enhance academic programming and training for biotechnology careers for North Carolina A&T students. A process laboratory will allow opportunities for students to put knowledge into practice in an advanced discovery setting. The 4,025-square-foot facility, expected to be completed in 2024, will include manufacturing and research components with vaccine manufacturing process training for new and existing Merck employees. he collaboration will add significantly to biotechnology research and education already underway in colleges and departments across A&T. In addition to biotechnology and bioengineering degree and certificate programs in the Joint School of Nanoscience and Nanoengineering, the colleges of Engineering, Science and Technology, and Agriculture and Environmental Sciences, the university is developing a Department of Defense-funded Center of Excellence in Biotechnology. www.ncat.edu/news/2023/06/merck-gateway-biotechnology.php
|
|